SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030897
Filing Date
2019-08-08
Accepted
2019-08-08 17:07:30
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q toca-10q_20190630.htm 10-Q 2038882
2 EX-10.1 toca-ex101_352.htm EX-10.1 90534
3 EX-10.2 toca-ex102_353.htm EX-10.2 71289
4 EX-31.1 toca-ex311_6.htm EX-31.1 9774
5 EX-31.2 toca-ex312_15.htm EX-31.2 9447
6 EX-32.1 toca-ex321_12.htm EX-32.1 6494
  Complete submission text file 0001564590-19-030897.txt   6476908

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT toca-20190630.xml EX-101.INS 1409513
8 XBRL TAXONOMY EXTENSION SCHEMA toca-20190630.xsd EX-101.SCH 38521
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE toca-20190630_cal.xml EX-101.CAL 41982
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE toca-20190630_def.xml EX-101.DEF 121904
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE toca-20190630_lab.xml EX-101.LAB 307070
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE toca-20190630_pre.xml EX-101.PRE 231229
Mailing Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121 (858) 412-8400
Tocagen Inc (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38052 | Film No.: 191010492
SIC: 2834 Pharmaceutical Preparations